New Research Finds FREZZOR Manuka Honey UAF1000+ is More Potent

IRVINE, Calif. - Aug. 9, 2021 - PRLog -- Whanganui, New Zealand, FREZZOR New Zealand, a Nutraceutical products company with production facilities in New Zealand and sales offices in Europe, China, and the USA, released today the results of scientific studies into its premium-grade certified manuka honey called Manuka Honey UAF1000+.

The Company's founder and CEO, Noel Turner, a pioneer and legendary figure in the New Zealand green-lipped mussel industry, stated, "the results are very very impressive, and we already see growth in sales as a result."

As part of this research, a third-party research lab investigated the anti-inflammatory capacity of Noel Turner's antioxidant superfood combination called UAF1000+. This antioxidant blend was created by Noel Turner to significantly increase the bioactivity and modulate the body's inflammatory response when combined with FREZZOR New Zealand nutritional products, such as certified raw manuka honey.

The Company asserts that New Zealand grown plants produce higher levels of bioactive plant compounds than identical plants grown in other regions of the world. This effect occurs from a large hole in the protective ozone layer above New Zealand, where elevated levels of unfiltered and damaging ultra-violet (UV) light radiate onto NZ plants and marine-life every day.

Previous research proves that plants protect themselves from UV light by increasing the production of bioactive compounds within their cells. These compounds act as the plant's natural sunscreen and protect the plant from further UV exposure. These highly bioactive plant compounds are potent antioxidants and metabolites that have important human health benefits.

What the Research Showed

The investigating scientific research team discovered that once certain NZ grown plant extracts were combined with an activating mineral extract in a specific way, the proprietary patent-pending blend, which is called UAF1000+, was able to block the entire inflammatory response as measured by the production of the inflammatory marker called interleukin-1b (IL-1b) in a cell-based assay.

After this initial benchmark was concluded, the UAF1000+ blend was added to certified manuka honey to assess the reduction in the inflammatory response. The result was a remarkable 39% reduction in inflammatory response with the UAF1000+ infused manuka honey compared to standard manuka honey alone.

The Wellington-based research scientists have confirmed that these results set a new standard of bioactivity for New Zealand produced Manuka Honey. While the health benefits of standard New Zealand manuka honey have been well publicized over the years, this is the first time that blended Manuka honey has been tested and proven to be effective in this way.

FREZZOR New Zealand

15215 Alton Parkway, Suite 140

Email: customercare@frezzor.com

Website: http://frezzor.com